Bayer’s Deadly Birth-Control Pills: Alleged Toll Climbs to 190, Shareholders Revolt
About 190 women have died while taking Yaz and Yasmin, Bayer’s two leading contraceptive pill brands, according to the Swiss media, and the company faces a shareholder motion condemning its marketing of the brands at its April 29 annual meeting.
About 190 women have died while taking Yaz and Yasmin, Bayer’s two leading contraceptive pill brands, according to the Swiss media, and the company faces a shareholder motion condemning its marketing of the brands at its April 29 annual meeting.
April 14, 2011, BNET CBS Business Network
Bayer’s Deadly Birth-Control Pills: Alleged Toll Climbs to 190, Shareholders Revolt
About 190 women have died while taking Yaz and Yasmin, Bayer’s two leading contraceptive pill brands, according to the Swiss media, and the company faces a shareholder motion condemning its marketing of the brands at its April 29 annual meeting.
The vote is unlikely to pass, but it will draw attention to Bayer’s increasing problems on its contraceptive franchise. Through February 2011, Bayer faces 6,850 lawsuits in the U.S. accusing the pills of creating potentially lethal blood clots and gall bladder damage, according to page 242 of its annual report. The number of suits is growing fast. Last October, there were “only” 4,200 suits. In September, the total was just 2,000.
The number of fatalities alleged in those suits is unknown, but a little-noticed German-language report on Swiss Television last year claimed that a search of the FDA’s adverse event database found “in round figures” 140 deaths associated with Yasmin, and 50 with Yaz, the newer brand. Those numbers will be used against Bayer at its shareholder meeting.
Bad publicity: Customers dropping dead
The database contains unconfirmed reports that vary wildly in quality, so the true number of deaths will likely be lower. Nonetheless, the headline number coupled with the lawsuit count will make it harder for Bayer to publicize its argument that the pills’ new estrogen-progestin combination are not more dangerous than cheaper, older pills.
While all pharmaceuticals have a certain “death rate” associated with them, birth control pills are generally taken by young, healthy women who are unlikely to suddenly drop dead. That’s what makes any unusual death rate associated with birth control so alarming.
In 2009, the Yaz franchise was Bayer’s most valuable property, earning €1.2 million. Competition from cheap generics lopped off 13 percent of those sales in 2010, which declined to €1.1 billion. It’s now Bayer’s second-biggest revenue driver but it could end up being its number one problem. By Jim Edwards
http://www.bnet.com/blog/drug-business/bayer-8217s-deadly-birth-control-pills-alleged-toll-climbs-to-190-shareholders-revolt/7964
Victims of Bayer Contraceptives to appear at Shareholder Meeting
Please help! Coalition against BAYER Dangers seriously at risk
Coalition against BAYER Dangers
www.CBGnetwork.org (in English)
CBGnetwork@aol.com
Facebook: www.facebook.com/pages/Coordination-gegen-BAYER-Gefahren-CBG/127538777294665
Tel: (+49) 211-333 911 Fax: (+49) 211-333 940
please send an e-mail for receiving the English newsletter Keycode BAYER free of charge
Advisory Board
Prof. Juergen Junginger, designer
Prof. Dr. Juergen Rochlitz, chemist, former member of the German parliament
Wolfram Esche, attorney
Dr. Sigrid Müller, pharmacologist
Prof. Rainer Roth, social scientist
Eva Bulling-Schroeter, member of the German parliament
Prof. Dr. Anton Schneider, biologist
Dr. Janis Schmelzer, historian,
Dr. Erika Abczynski, pediatrician
Please help us. Our international campaigns are expensive to run. We receive no public support and depend entirely on your donations.
Please send checks to:
CBG, Postfach 15 04 18, 40081 Duesseldorf, Germany
or by bank transfer to bank account number 8016 533 000 at GLS Bank, Germany
sort code: 430 609 67
BIC/SWIFT Code: GENODEM1GLS
(Bank Identifier Code)
IBAN: DE88 4306 0967 8016 5330 00
(International Bank Account Number)
Please note that bank transfers within Europe are usually no more costly than within your own country, if you quote the BIC and IBAN numbers
You may also support us online
Bayer’s Deadly Birth-Control Pills: Alleged Toll Climbs to 190, Shareholders Revolt
About 190 women have died while taking Yaz and Yasmin, Bayer’s two leading contraceptive pill brands, according to the Swiss media, and the company faces a shareholder motion condemning its marketing of the brands at its April 29 annual meeting.
The vote is unlikely to pass, but it will draw attention to Bayer’s increasing problems on its contraceptive franchise. Through February 2011, Bayer faces 6,850 lawsuits in the U.S. accusing the pills of creating potentially lethal blood clots and gall bladder damage, according to page 242 of its annual report. The number of suits is growing fast. Last October, there were “only” 4,200 suits. In September, the total was just 2,000.
The number of fatalities alleged in those suits is unknown, but a little-noticed German-language report on Swiss Television last year claimed that a search of the FDA’s adverse event database found “in round figures” 140 deaths associated with Yasmin, and 50 with Yaz, the newer brand. Those numbers will be used against Bayer at its shareholder meeting.
Bad publicity: Customers dropping dead
The database contains unconfirmed reports that vary wildly in quality, so the true number of deaths will likely be lower. Nonetheless, the headline number coupled with the lawsuit count will make it harder for Bayer to publicize its argument that the pills’ new estrogen-progestin combination are not more dangerous than cheaper, older pills.
While all pharmaceuticals have a certain “death rate” associated with them, birth control pills are generally taken by young, healthy women who are unlikely to suddenly drop dead. That’s what makes any unusual death rate associated with birth control so alarming.
In 2009, the Yaz franchise was Bayer’s most valuable property, earning €1.2 million. Competition from cheap generics lopped off 13 percent of those sales in 2010, which declined to €1.1 billion. It’s now Bayer’s second-biggest revenue driver but it could end up being its number one problem. By Jim Edwards
http://www.bnet.com/blog/drug-business/bayer-8217s-deadly-birth-control-pills-alleged-toll-climbs-to-190-shareholders-revolt/7964 Victims of Bayer Contraceptives to appear at Shareholder Meeting
Please help! Coalition against BAYER Dangers seriously at risk
Coalition against BAYER Dangers
www.CBGnetwork.org (in English)
CBGnetwork@aol.com Facebook: www.facebook.com/pages/Coordination-gegen-BAYER-Gefahren-CBG/127538777294665
Tel: (+49) 211-333 911 Fax: (+49) 211-333 940
please send an e-mail for receiving the English newsletter Keycode BAYER free of charge
Advisory Board
Prof. Juergen Junginger, designer
Prof. Dr. Juergen Rochlitz, chemist, former member of the German parliament
Wolfram Esche, attorney
Dr. Sigrid Müller, pharmacologist
Prof. Rainer Roth, social scientist
Eva Bulling-Schroeter, member of the German parliament
Prof. Dr. Anton Schneider, biologist
Dr. Janis Schmelzer, historian,
Dr. Erika Abczynski, pediatrician
Please help us. Our international campaigns are expensive to run. We receive no public support and depend entirely on your donations.
Please send checks to:
CBG, Postfach 15 04 18, 40081 Duesseldorf, Germany
or by bank transfer to bank account number 8016 533 000 at GLS Bank, Germany
sort code: 430 609 67
BIC/SWIFT Code: GENODEM1GLS
(Bank Identifier Code)
IBAN: DE88 4306 0967 8016 5330 00
(International Bank Account Number)
Please note that bank transfers within Europe are usually no more costly than within your own country, if you quote the BIC and IBAN numbers
You may also support us online
e-mail:
Homepage:
